{"id":54820,"date":"2023-03-14T15:07:54","date_gmt":"2023-03-14T14:07:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/"},"modified":"2023-03-14T15:07:54","modified_gmt":"2023-03-14T14:07:54","slug":"geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/","title":{"rendered":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast"},"content":{"rendered":"
\n

\n\u00a0\n<\/p>\n

MOOSIC, Pa.–(BUSINESS WIRE)–Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital being built through a joint venture partnership<\/a> between Geisinger and Acadia in Moosic.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nMs. Ankenbrand succeeds Jenna Pacini. Ms. Pacini was named CEO in August 2022 with Ms. Ankenbrand as CEO-in-Training and Pacini\u2019s successor. Ms. Ankenbrand completed her training ahead of schedule and with exceptional results. Ms. Pacini will now become the CEO of another Acadia hospital.\n<\/p>\n

\nIn her new role, effective March 6, Ms. Ankenbrand will oversee the development of the facility including staff recruitment and training, clinical programming design and oversight of all key functions leading to the opening of the new hospital.\n<\/p>\n

\n\u201cI am honored to be named as the new CEO of Geisinger Behavioral Hospital Northeast,\u201d said Ms. Ankenbrand. \u201cThe partnership of Geisinger and Acadia Healthcare promises to bring the highest quality of behavioral healthcare to our community. I look forward to being part of this journey as we build a culture of compassion and service with high standards for clinical excellence to meet the needs of the community we serve.\u201d\n<\/p>\n

\nThe joint venture partnership is helping to address the increased need for mental health care in Pennsylvania. According to data from the National Alliance on Mental Illness (NAMI), 1 in 5 U.S. adults experience mental illness each year. Three out of 5 Pennsylvania communities do not have enough mental health providers, and more than 1.8 million adults in Pennsylvania have a mental health condition.\n<\/p>\n

\nGeisinger Behavioral Health Center Northeast is the first of two hospitals that the joint venture plans to build to bring high-quality inpatient behavioral health services to central and northeastern Pennsylvania. The second new freestanding inpatient behavioral health hospital \u2013 Geisinger Behavioral Health Center Central \u2013 will be constructed in Danville. Both hospitals will serve adult and pediatric patients.\n<\/p>\n

\n\u201cWe are very excited to have a leader of Kelly\u2019s caliber guiding the new hospital in Moosic,\u201d said Dawn Zieger, vice president of psychiatry and behavioral health for Geisinger. \u201cWe want to thank Jenna for her strong leadership of the hospital through this important phase of development and for training Kelly for her new role. We are pleased that in partnership with Geisinger, our shared vision of a state-of-the-art behavioral health hospital is on track to become reality in August this year.\u201d\n<\/p>\n

\nPrior to joining Geisinger Behavioral Health Hospital Northeast, Ms. Ankenbrand served as the Vice President of Behavioral Health Services for the Commonwealth Health Network in Northeastern Pennsylvania. She has played a critical role in the delivery of community and hospital-based psychiatric services throughout the surrounding community for the last 25 years.\n<\/p>\n

\nMs. Ankenbrand earned her Bachelor of Arts in Psychology and English from Wilkes University and her Master of Business Administration from the University of Scranton. Her involvement in the community goes beyond the delivery of care to include the development and implementation of training programs to support first responders and serving as co-president of the NAMI Northeast Region of Pennsylvania.\n<\/p>\n

\nAbout Geisinger<\/b>\n<\/p>\n

\nGeisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org<\/a> or connect with us on Facebook<\/a>, Instagram<\/a>, LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

\nAbout Acadia Healthcare<\/b>\n<\/p>\n

\nAcadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2022, Acadia operated a network of 250 behavioral healthcare facilities with approximately 11,000 beds in 39 states and Puerto Rico. With approximately 23,000 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nGeisinger:<\/b>
Ashley Andyshak Hayes
\n
717-521-9757
\n
arandyshakhayes@geisinger.edu<\/a>\n<\/p>\n

\nAcadia Healthcare:<\/b>
Gretchen Hommrich
\n
(615) 861-6000\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u00a0 MOOSIC, Pa.–(BUSINESS WIRE)–Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital being built through a joint venture partnership between Geisinger and Acadia in Moosic. Ms. Ankenbrand succeeds Jenna Pacini. Ms. Pacini was named CEO in August 2022 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54820","6":"format-standard","7":"category-industry"},"yoast_head":"\nGeisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u00a0 MOOSIC, Pa.–(BUSINESS WIRE)–Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital being built through a joint venture partnership between Geisinger and Acadia in Moosic. Ms. Ankenbrand succeeds Jenna Pacini. Ms. Pacini was named CEO in August 2022 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T14:07:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast\",\"datePublished\":\"2023-03-14T14:07:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/\"},\"wordCount\":713,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005483\\\/en\\\/1737687\\\/21\\\/Kelly_Ankenbrand_photo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/\",\"name\":\"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005483\\\/en\\\/1737687\\\/21\\\/Kelly_Ankenbrand_photo.jpg\",\"datePublished\":\"2023-03-14T14:07:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005483\\\/en\\\/1737687\\\/21\\\/Kelly_Ankenbrand_photo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005483\\\/en\\\/1737687\\\/21\\\/Kelly_Ankenbrand_photo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/","og_locale":"en_US","og_type":"article","og_title":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend","og_description":"\u00a0 MOOSIC, Pa.–(BUSINESS WIRE)–Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital being built through a joint venture partnership between Geisinger and Acadia in Moosic. Ms. Ankenbrand succeeds Jenna Pacini. Ms. Pacini was named CEO in August 2022 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-14T14:07:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast","datePublished":"2023-03-14T14:07:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/"},"wordCount":713,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/","url":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/","name":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg","datePublished":"2023-03-14T14:07:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230314005483\/en\/1737687\/21\/Kelly_Ankenbrand_photo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/geisinger-and-acadia-healthcare-appoint-kelly-ankenbrand-as-ceo-of-geisinger-behavioral-health-center-northeast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54820"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54820\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}